Three Fellows in the Department of Pathology and the Center for Cardiovascular Diseases and Sciences have been awarded Fellowships funding their ongoing research into cardiovascular diseases.
Welcome to the Department of Pathology at Louisiana State University Health Shreveport. The Department of Pathology is composed of an outstanding faculty of 28 faculty members, 12 residents, 3 fellows, and almost 200 administrative and laboratory staff. We provide diagnostic services to patients within our hospital system and numerous patients regionally, nationally and internationally via our ever expanding Pathology Outreach Services program. We at LSU Health Shreveport Pathology Outreach Services realize that quality and efficiency are of the utmost importance in delivering the best care possible to your patients. Our employees continuously strive to ensure that each client receives the highest quality, accuracy, and technologically advanced services available. Most importantly, it is our commitment to providing a personal touch, range of services, and highly qualified personnel that sets us apart from other facilities.
Our Anatomic and Clinical Laboratories are CAP, AABB, FDA, and JCAHO accredited with all technical personnel being appropriately licensed both at the national and state level. Additionally, many technical personnel also possess a specialist license in their area of expertise. Our technical staff is trained in handling all accounts, regardless of size, in an individualized manner to insure that customer specifications are continuously achieved.
Our Anatomic Pathology Division and Clinical Pathology Division technical and administrative personnel are not only knowledgeable but highly experienced in their area of expertise and embrace a team approach to quality care, education and research.
Our Pathology Research Division brings in over $3.2 million in extramural funding from the National Institute of Health, which ranks #46 nationally among Pathology Departments.
Thank you for visiting and giving us the opportunity to share with you our pathology department. We believe that professionalism, teamwork, personalized methods, quality patient care, higher education and research are the foundation of a successful and brighter future for all.
At LSU Health Shreveport, we offer a wide variety of consultative services in both Anatomic and Clinical Pathology. If you don’t find what you need on our website please contact us.
Pathology Central Receiving: (888) 252-3902
Phone: (318) 675-5860
Fax: (318) 675-8589
Residency / Fellowship
Phone: (318) 675-7822
Fax: (318) 675-7966
Phone: (318) 675-5869
Fax: (318) 675-6444
Phone: (318) 675-8475
Fax: (318) 675-7514
Phone: (318) 675-5861
Fax: (318) 675-8144
Patient Client Services
Phone: (318) 675-5918
Fax: (318) 675-4568
Our Anatomic Pathology Division and Clinical Pathology Division technical and administrative personnel are not only knowledgeable but highly experienced in their area of expertise and embrace a team approach to quality care, education, and research.
Many of our clinical faculty members are leaders in their fields and enjoy national and international reputations. They participate in key national committees and serve in leadership roles in major national and international medical societies. They are truly engaged in the advancement of medical knowledge. Their publication record is excellent and they actively involve trainees in their research projects.
Anatomic Pathology has a diverse list of specialties and over 25 full-time faculty members. Diagnostic consensus sign out conferences multiple times per week provide the framework for diagnostic excellence in the many subspecialty areas.
Hematology studies the blood and blood-forming tissues to evaluate presence of disease and assist in therapeutic interventions as clinically indicated. LSU Health Shreveport has highly qualified technical staff to assist you with any question in this area.
Molecular Pathology is the study of disease and chromosomal abnormalities at the molecular level to aid in diagnosis and therapeutic intervention of disease processes. The three areas of testing include genetics, hematopathology, and infectious disease.
Clinical Pathology has eight full time subspecialty trained and Board Certified Faculty. Oversight is provided for our Hematopathology, Wet Hematology, Coagulation, Flow Cytometry, Blood Bank, Apheresis, Routine and Special Chemistry and Point of Care, Lab Information, Microbiology, Virology, Parasitology, Cytogenetics, and Molecular Genetics Services.
Our combined research explores cell-matrix interactions, cell signaling, biochemical redox biology, and regulation of autophagy in chronic inflammation and cardiovascular remodeling.
JanOne Acquires Worldwide, Exclusive License for Promising Treatment of Peripheral Arterial Disease (PAD), TV1001SR, which was invented by LSU Health Shreveport professor and vice chancellor for research, Dr. Chris Kevil.
LSU Health Shreveport is excited to announce we will be attending the upcoming USCAP 2019 Annual Meeting. The USCAP meeting will be held at the National Harbor, Maryland, March 16-21, 2019.
On September 26 – 27th, 2019, LSU Health Shreveport will host Dr. Barbara Ducatman as she reviews interesting cases.
Rodney Shackelford, DO, PhD, Assistant Professor of Pathology, has been awarded a $40,000 grant from the A-T Children’s Project for his research project titled, “Pharmacologic Correction of the Cellular Sulfide Pool as a Treatment for Ataxia-Telangiectasia.”
Dr. Yufeng Dong's lab in the Department of Orthopaedics and Dr. Chris Kevil's lab in the Department of Pathology wrote a collaborative review article, "Notch Signaling in Osteogenesis, Osteoclastogenesis, and Angiogenesis," published in The American Journal of Pathology
LSU Health Shreveport researchers recently presented preliminary findings at the American Heart Association’s Basic Cardiovascular Sciences 2019 Scientific Sessions that use of the illegal stimulant methamphetamine causes build-up of tough protein fibers in heart muscle, which may help explain the development of enlarged hearts and heart failure in users.
Zaki Al Yafeai, Dr. Celeste Wu, Dr. Shafiul Alam and Alexandre Do Couto E Silva were recognized as American Heart Association Fellowship recipients.
The goal by Md. Shenuarin Bhuiyan, PhD, is to discover a novel lipid metabolism pathway regulated by Sigmar1 and identify a therapeutic target to prevent lipid abnormalities in obesity, expected to help reverse the impact of obesity on cardiovascular disease risk.